You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
GaAsSb/AlGaAsP Superlattice Polarized Electron Source
SBC: SVT ASSOCIATES INC Topic: 41eThe negative-electron-affinity (NEA) photocathodes which produce polarized electrons are a vital component of electron accelerators such as that at the Stanford Linear Accelerator Center (SLAC) and DoE Jefferson Lab. Future systems, such as the International Linear Collider (ILC), will require a polarized electron beam intensity at least 20 times greater than produced by strained GaAs, which is us ...
SBIR Phase I 2013 Department of Energy -
High-Energy, High-Power Light Weight Lithium Ion Batteries For Electric Drive Vehicle
SBC: Yardney Technical Products, Inc. Topic: 06aElectric vehicles, hybrid electric vehicles, and plugin hybrid electric vehicles (EVs, HEVs, and PHEVs) are emerging technologies that can significantly reduce petroleum usage in the transportation sector. Widespread adoption of electricdrive vehicles will lower automobile operation costs and can significantly decrease emissions of greenhouse gases. However, for these technologies to be successful ...
SBIR Phase I 2013 Department of Energy -
Optimization Using Metamodeling in the Context of Integrated Computational Materials Engineering (ICME)
SBC: PREDICTIVE DESIGN TECHNOLOGIES LLC Topic: 02aPredictive Design Technologies, LLC (PDT) proposes to employ Integrated Computational Materials Engineering (ICME) tools to help manufacturing industry in the United States. ICME uses computational materials science tools within a holistic system in order to accelerate materials development, improve design optimization, and unify design and manufacturing. With the advent of accurate modeling and s ...
STTR Phase I 2013 Department of Energy -
Real-Time Size-Distributed Measurement of Aerosol Mass Concentration
SBC: MSP CORPORATION Topic: 03eIn atmospheric aerosol research, size-distributed aerosol samples are often collected with airborne instrumentation, but are not analyzed in any manner until after they are brought to a laboratory on the ground. The information thus obtained is averaged for all the locations covered during the mission. A novel technology is being developed in this project to constantly measure the size-distributed ...
SBIR Phase II 2013 Department of Energy -
GaAsSb/AlGaAs Superlattice High-Polarization Electron Source
SBC: SVT ASSOCIATES INC Topic: 34eThe negative-electron-affinity (NEA) photocathodes which produce polarized electrons are a vital component of electron accelerators such as that at DoE Jefferson Lab and the Stanford Linear Accelerator Center (SLAC). Future systems, such as the International Linear Collider (ILC), will require a polarized electron beam intensity at least 20 times greater than produced by strained GaAs, which is u ...
SBIR Phase II 2013 Department of Energy -
Orally Active Formulations of DHA Dimers for the Treatment of Infectious Diseases
SBC: ElSohly Laboratories, Incorporated Topic: NIAIDDESCRIPTION (provided by applicant): The natural product artemisinin is a sesquiterpene endoperoxide with known anti-malarial activity against both chloroquine-sensitive and chloroquine-resistant strains of the parasite Plasmodium falciparum. In addition to its anti-malarial activity, artemisinin was reported to have cytotoxic activity against several different tumor cell lines. Recently, artemisi ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Live-Cell Fluorescence Lifetime FRET Assays for HTS
SBC: Fluorescence Innovations, Inc. Topic: NIDADESCRIPTION (provided by applicant): This project will establish proof-of-concept for a powerful and versatile implementation of live-cell assays in a true high-throughput screening (HTS) format for small-molecule drug discovery. The technological basis isfluorescence lifetime (FLT) readout of FRET between fluorescent fusion proteins. Lifetime measurement is needed in HTS to overcome the low preci ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Body Worn EMG Controlling of Assistive Robotic Arm for Stroke Rehabilitation
SBC: ADVANCED MEDICAL ELECTRONICS CORP Topic: NINDSDESCRIPTION (provided by applicant): Stroke is the leading cause of adult disability and the third leading cause of death in the United States. Approximately 15 million people in the world, and more than 700,000 people in the United States, experience a stroke each year. Following a hemispheric stroke, motor control of extremities on one side of the body is usually affected. Many patients suffer a ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
The Bumps ad device for rapid non invasive quantification of touch sensation
SBC: Neuro Devices, Inc. Topic: NCATSDESCRIPTION (provided by applicant): Our proposal describes an elegant device called the Bumps that quantifies touch sensation on the fingers at low micron levels. The objectives are to diagnose peripheral neuropathy near its onset, when the possibility for reversal is highest, and to monitor either progression or reversal of neuropathy during treatment. Target neuropathies are those related to ch ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Therapy Management Software for Naturalistic Model-Based Behavioral Interventions
SBC: GENESEGUES INC Topic: NIAIDDESCRIPTION (provided by applicant): The ultimate goal of this project is to develop a safe and effective topical vaccine against the dengue virus (DENV). DENV causes an estimated 30 to 50 million cases of debilitating fever leading to over 20,000 deaths worldwide every year. DNA-based vaccines have great potential against DENV because they can more quickly generate a balanced immune response, are ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health